SCHEMBL242948

SCHEMBL242948

C(/C=N/c1ccccc1)=N\c1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S100B P04271 1/20 0.52
KMT2A Q03164 7/20 0.50
ALDH1A1 P00352 4/20 0.50
MAOA P21397 1/20 0.44
KDM4E B2RXH2 2/20 0.41
GLA P06280 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
MAPT P10636 6/20 0.40
MEN1 O00255 5/20 0.40
GAA P10253 2/20 0.40
NPSR1 Q6W5P4 2/20 0.40
LMNA P02545 1/20 0.40
THRB P10828 1/20 0.40
RECQL P46063 1/20 0.40
MIF P14174 1/20 0.39
HTR3E A5X5Y0 1/20 0.39
SLC22A2 O15244 1/20 0.39
SLC22A1 O15245 1/20 0.39
SLC22A3 O75751 1/20 0.39
HTR3B O95264 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL242949 1.00 S100B (0.52) S100BKMT2AALDH1A1MAOAKDM4E
SCHEMBL13754812 1.00 S100B (0.52) S100BKMT2AALDH1A1MAOAKDM4E
SCHEMBL5676571 0.97 S100B (0.50) S100BKMT2AALDH1A1MAOAKDM4E
SCHEMBL4865610 0.97 S100B (0.50) S100BKMT2AALDH1A1MAOAKDM4E
SCHEMBL22238367 0.89 S100B (0.44) S100BKMT2AALDH1A1MAOAKDM4E
SCHEMBL23367976 0.83 KMT2A (0.44) S100BKMT2AALDH1A1MAOAKDM4E
SCHEMBL156585 0.83 KMT2A (0.44) S100BKMT2AALDH1A1MAOAKDM4E
SCHEMBL7089228 0.83 KMT2A (0.44) S100BKMT2AALDH1A1MAOAKDM4E
SCHEMBL10189846 0.83 KMT2A (0.44) S100BKMT2AALDH1A1MAOAKDM4E
Hydrochloric Acid SCHEMBL10938474 0.81 KMT2A (0.42) S100BKMT2AALDH1A1MAOAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 233 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1363923-B1 RHODIUM AND IRIDIUM COMPLEXES MERCK PATENT GMBH (DE) 2009-04-01 EP claimed
EP-1562964-B1 PALLADIUM AND PLATINUM COMPLEXES MERCK PATENT GMBH (DE) 2006-07-19 EP claimed
US-20040138455-A1 Rhodium and iridium complexes MERCK PATENT GMBH (DE) 2004-07-15 US claimed
US-12635401-B2 Metal complexes UDC Ireland (IE) 2026-05-19 US disclosed
US-12544733-B2 Gas/liquid oligomerization reactor having successive zones with variable diameters IFP Energies Nouvelles (FR) 2026-02-10 US disclosed
US-12479780-B2 Oligomerisation process comprising a step of recycling a pre-cooled solvent IFP Energies Nouvelles (FR) 2025-11-25 US disclosed
US-12364960-B2 Method for oligomerization in a reactor comprising a gas/liquid double distributor IFP Energies Nouvelles (FR) 2025-07-22 US disclosed
WO-2025119896-A1 METHOD FOR OLIGOMERISING AN OLEFIN FEEDSTOCK IN A TUBULAR LOOP REACTOR IFP Energies Nouvelles (FR) 2025-06-12 WO disclosed
US-12312288-B2 Gas/liquid oligomerization reactor comprising transverse internals IFP Energies Nouvelles (FR) 2025-05-27 US disclosed
EP-4069709-B1 METAL COMPLEXES UDC IRELAND LTD (IE) 2025-04-23 EP disclosed
US-20250084014-A1 OLIGOMERISATION PROCESS COMPRISING A STEP OF RECYCLING A PRE-COOLED SOLVENT IFP Energies Nouvelles (FR) 2025-03-13 US disclosed
US-20030225303-A1 Hydroformylation process employing a cobalt-based catalyst in a non-aqueous liquid with improved catalyst recycling INSTITUT FRANCAIS DU PETROLE (FR) 2003-12-04 US disclosed
EP-1352889-A1 Hydroformylation process using a cobalt catalyst in a non-aqueous ionic liquid with catalyst recycle INSTITUT FRANCAIS DU PETROLE (FR) 2003-10-15 EP disclosed
US-6617474-B2 Reacting olefinically unsaturated compound with carbon monoxide and hydrogen in presence of polar phase comprising: a non-aqueous ionic liquid comprising quaternary ammonium and/or a quaternary phosphonium compound and catalyst; adding solvent INSTITUT FRANCAIS DU PETROLE (FR) 2003-09-09 US disclosed
US-20030055299-A1 Catalyst based on cobalt and/or rhodium employed in a two-phase medium INSTITUT FRANCAIS DU PETROLE (FR) 2003-03-20 US disclosed
US-6469216-B2 CO OR RH COMPLEX COORDINATED WITH A NITROGEN-CONTAINING LIGAND; QUATERNARY AMMONIUM OR PHOSPHONIUM IONIC SOLVENT INSTITUT FRANCAIS DU PETROLE (FR) 2002-10-22 US disclosed
EP-1241156-A1 Process for the hydroformylation of olefinic unsaturated compounds in a non-aqueous ionic solvent INSTITUT FRANCAIS DU PETROLE (FR) 2002-09-18 EP disclosed
US-20020099243-A1 Process for the hydroformylation of olefinically unsaturated compounds in a non-aqueous ionic solvent INSTITUT FRANCAIS DU PETROLE (FR) 2002-07-25 US disclosed
US-20010039363-A1 Process for hydroformylation using a catalyst based on cobalt and/or rhodium employed in a two-phase medium INSTITUT FRANCAIS DU PETROLE (FR) 2001-11-08 US disclosed
EP-1106595-A1 Improved hydroformylation process with cobalt and/or rhodium based catalysts in a biphasic medium INSTITUT FRANCAIS DU PETROLE (FR) 2001-06-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12544733-B2 Gas/liquid oligomerization reactor having successive zones with variable diameters NOD1, VAT1, DECR1 S100B 4558/4885KMT2A 4754/4885ALDH1A1 4120/4885
US-12635401-B2 Metal complexes SCO2, SOD1, NR4A1 S100B 3101/4885KMT2A 2648/4885ALDH1A1 2069/4885
US-20040138455-A1 Rhodium and iridium complexes RPIA, MPI, INPP5B S100B 2508/4885KMT2A 4167/4885ALDH1A1 2213/4885
US-12479780-B2 Oligomerisation process comprising a step of recycling a pre-cooled solvent COG4, PRPF40A, PRPF6 S100B 2340/4885KMT2A 4847/4885ALDH1A1 3272/4885
US-12312288-B2 Gas/liquid oligomerization reactor comprising transverse internals DCXR, OTUB1, INF2 S100B 2453/4885KMT2A 4605/4885ALDH1A1 4344/4885
US-20020099243-A1 Process for the hydroformylation of olefinically unsaturated compounds in a non-aqueous ionic solvent NUDT1, PHOSPHO1, SRSF6 S100B 1842/4885KMT2A 2397/4885ALDH1A1 2394/4885
US-20250084014-A1 OLIGOMERISATION PROCESS COMPRISING A STEP OF RECYCLING A PRE-COOLED SOLVENT COG4, PRPF40A, PRPF6 S100B 2340/4885KMT2A 4847/4885ALDH1A1 3272/4885
US-12364960-B2 Method for oligomerization in a reactor comprising a gas/liquid double distributor DUOX2, COASY, DUOX1 S100B 3866/4885KMT2A 4776/4885ALDH1A1 4579/4885
US-20030225303-A1 Hydroformylation process employing a cobalt-based catalyst in a non-aqueous liquid with improved catalyst recycling NUDT1, AP2S1, SRSF1 S100B 2437/4885KMT2A 1499/4885ALDH1A1 2329/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.